Isaac Newton first separated light with a prism and discovered the visible spectrum. Newton demonstrated the wave character of light.
At the turn of the last century, A Nobel Prize was awarded to a Danish doctor for using ultraviolet light in successful medical treatments. While developing the Theory of Relativity, Albert Einstein theorized the laser. L.A.S.E.R. stands for Light Amplification by Stimulated Emission of Radiation. He proposed that when a proper photon collides with a properly excited atom, two photons of the same energy level would be emitted. He theorized that light has both the properties of a wave and a particle.
Howard Hughes founded an aircraft research laboratory where Theodore Maiman created what Einstein imagined and constructed the first laser in 1960. Maiman produced a ruby laser spurring rapid growth and fast development. Shortly thereafter, far away in Western Europe, Endre Mester, the father of laser therapy, published his findings in an obscure Hungarian medical journal. Sociopolitical factors caused Hungarians to research in isolation for a decade.
During the Seventies, the Soviet Union and China rapidly adapted laser therapy and Canadian researchers concluded that therapeutic lasers offer a viable alternative to traditional needle acupuncture.
During the Eighty's, laser therapy became rapidly popular in Europe with the development of solid state laser diodes. America was late to adapt the technology partially due to sociopolitical factors. All of the research was published in multiple foreign languages.
In 1993 the Independent Institutional review Board for Laser Acupuncture Research was established in Boston, Massachusetts. In 1997 the U.S. National Institute of Health gave approval to the practice of acupuncture. The North American Association for Laser Therapy (NAALT) was established in 1998 to review photobiological mechanisms, basic laser physics, treatment parameters, techniques, scientific and clinical laser communities and regulatory issues.
There are over 30,000 treatments using therapeutic lasers which have been in practice and studied for over 35 years. There are over 2,500 studies and papers already published with thousands of practitioners using therapeutic lasers clinically in Europe, Asia, and North America. The U.S. Food and Drug Administration classified cold lasers as a "non-significant risk device." The FDA has approved a few therapeutic lasers for specific, limited applications and is currently conducting clinical trials for other laser therapies.
AcuLASER believes that Cold LASER Therapy is a disruptive technology that will fundamentally transform the healthcare system of the United States of America. We are hopeful that healthcare insurance providers and corporations will recognize the advantages of this cost effective treatment modality and push for it's inclusion in healthcare plans. AcuLASER is actively lobbying congress and major health insurance carriers to cover our Cold LASER Auriculotherapy treatment protocols as a preventative maintenance procedure. The current administration seems to be receptive to preventative healthcare and we are optimistic.